TuHURA BIOSCIENCES, INC./NV Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2025-11-10: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-10-27; Total offering amount $3,000,000.
- 2025-06-13: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-06-02; Total offering amount $12,612,120.
- 2020-08-28: Federal exemption Rule 506(b); Types of securities offered Equity; Series C Convertible Preferred Stock; Date of first sale 2020-08-19; Total offering amount $30,000,000.
- 2020-08-27: Federal exemption Rule 506(b); Types of securities offered Equity; Series C Convertible Preferred Stock; Date of first sale 2020-08-19; Total offering amount $30,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2025-10-27 | $3,000,000 | $1,500,000 | $1,500,000 | 1 |
| 2025-06-13 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2025-06-02 | $12,612,120 | $2,228,043 | $10,384,077 | 36 |
| 2020-08-28 | Rule 506(b) | Equity; Series C Convertible Preferred Stock | 2020-08-19 | $30,000,000 | $21,772,000 | $8,228,000 | 161 |
| 2020-08-27 | Rule 506(b) | Equity; Series C Convertible Preferred Stock | 2020-08-19 | $30,000,000 | $21,772,000 | $8,228,000 | 161 |
| 2013-03-07 D/A | Rule 506 | Equity; OptionToAcquire | 2013-01-25 | $10,500,000 | $10,500,000 | $0 | 102 |
| 2013-02-14 D/A | Rule 506 | Equity; OptionToAcquire | 2013-01-25 | $10,000,000 | $7,928,550 | $2,071,450 | 70 |
| 2013-02-08 D/A | Rule 506 | Equity; OptionToAcquire | 2013-01-25 | $10,000,000 | $6,887,450 | $3,112,550 | 48 |
| 2013-02-08 | Rule 506 | Equity; OptionToAcquire | 2013-01-25 | $10,000,000 | $6,887,450 | $3,112,550 | 48 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |